← All trials
NCT01896284
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2013
- Primary completion
- Mar 1, 2014
- Completion date
- Mar 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 43
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Barcelona Macula FoundationLead sponsor
- BayerCollaborator
- Barcelona Macula FoundationOverall official - principal investigator
- Hospital Son EspasesOverall official - principal investigator
- Hospital Universitari General de CatalunyaOverall official - principal investigator
- Hospital Universitario de AlbaceteOverall official - principal investigator
- Institut Catala de RetinaOverall official - principal investigator
- University of Las Palmas de Gran CanariaOverall official - principal investigator
- TFS Trial Form SupportCollaborator
- Universidad Complutense de MadridOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.